110 related articles for article (PubMed ID: 38578024)
1. RNA modification-related EIF4G2 is an immunotherapy determinant in osteosarcoma: A single-cell sequencing analysis.
Qin H; Yang S; Feng Z; Wu S; Cai T; Xie Z; Hu H
Environ Toxicol; 2024 Apr; ():. PubMed ID: 38578024
[TBL] [Abstract][Full Text] [Related]
2. Single-cell and bulk RNA sequencing reveals Anoikis related genes to guide prognosis and immunotherapy in osteosarcoma.
Zhong C; Yang D; Zhong L; Xie W; Sun G; Jin D; Li Y
Sci Rep; 2023 Nov; 13(1):20203. PubMed ID: 37980450
[TBL] [Abstract][Full Text] [Related]
3. Antigen processing and presentation-related signature-derived BNIP3 is a novel oncogene and immunotherapy determinant in osteosarcoma based on machine learning and in vitro validation.
Chen Y; Cao Y; Wu S; Cao X; Cai T; Hu H
J Gene Med; 2024 Jan; 26(1):e3586. PubMed ID: 37655535
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-379 inhibits the proliferation, migration and invasion of human osteosarcoma cells by targetting EIF4G2.
Xie X; Li YS; Xiao WF; Deng ZH; He HB; Liu Q; Luo W
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28381518
[TBL] [Abstract][Full Text] [Related]
5. Construction and validation of a novel gene signature for predicting the prognosis of osteosarcoma.
Yang J; Zhang A; Luo H; Ma C
Sci Rep; 2022 Jan; 12(1):1279. PubMed ID: 35075228
[TBL] [Abstract][Full Text] [Related]
6. A four-lncRNA risk signature for prognostic prediction of osteosarcoma.
Liu H; Chen C; Liu L; Wang Z
Front Genet; 2022; 13():1081478. PubMed ID: 36685868
[No Abstract] [Full Text] [Related]
7. Prediction of Prognosis and Immunotherapy Response with a Novel Natural Killer Cell Marker Genes Signature in Osteosarcoma.
Li Q; Huang X; Zhao Y
Cancer Biother Radiopharm; 2023 Oct; ():. PubMed ID: 37889617
[No Abstract] [Full Text] [Related]
8. Combining single-cell sequencing data to construct a prognostic signature to predict survival, immune microenvironment, and immunotherapy response in gastric cancer patients.
Hu B; Meng Y; Qu C; Wang BY; Xiu DR
Front Immunol; 2022; 13():1018413. PubMed ID: 36300104
[TBL] [Abstract][Full Text] [Related]
9. A four-methylated LncRNA signature predicts survival of osteosarcoma patients based on machine learning.
Deng Y; Yuan W; Ren E; Wu Z; Zhang G; Xie Q
Genomics; 2021 Jan; 113(1 Pt 2):785-794. PubMed ID: 33069828
[TBL] [Abstract][Full Text] [Related]
10. Immunogenic cell death related mRNAs associated signature to predict immunotherapeutic response in osteosarcoma.
Han S; Wang Q; Shen M; Zhang X; Wang J
Heliyon; 2024 Mar; 10(6):e27630. PubMed ID: 38515694
[TBL] [Abstract][Full Text] [Related]
11. Construction of immune-related gene pairs signature to predict the overall survival of osteosarcoma patients.
Li LQ; Zhang LH; Zhang Y; Lu XC; Zhang Y; Liu YK; Khader MA; Jia-Wen ; Tao-Liu ; Li JZ
Aging (Albany NY); 2020 Nov; 12(22):22906-22926. PubMed ID: 33203792
[TBL] [Abstract][Full Text] [Related]
12. Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma.
Liu B; Liu Z; Feng C; Li C; Zhang H; Li Z; Tu C; He S
Front Endocrinol (Lausanne); 2022; 13():987942. PubMed ID: 36313774
[TBL] [Abstract][Full Text] [Related]
13. Construction of an ER stress-related prognostic signature for predicting prognosis and screening the effective anti-tumor drug in osteosarcoma.
Chen W; Liao Y; Sun P; Tu J; Zou Y; Fang J; Chen Z; Li H; Chen J; Peng Y; Wen L; Xie X
J Transl Med; 2024 Jan; 22(1):66. PubMed ID: 38229155
[TBL] [Abstract][Full Text] [Related]
14. Integrated analysis of single-cell and bulk RNA-sequencing reveals a novel signature based on NK cell marker genes to predict prognosis and immunotherapy response in gastric cancer.
Sun JR; Kong CF; Ye YX; Wang Q; Qu XK; Jia LQ; Wu S
Sci Rep; 2024 Apr; 14(1):7648. PubMed ID: 38561388
[TBL] [Abstract][Full Text] [Related]
15. Identification of a Novel Prognostic Gene Signature From the Immune Cell Infiltration Landscape of Osteosarcoma.
Fan L; Ru J; Liu T; Ma C
Front Cell Dev Biol; 2021; 9():718624. PubMed ID: 34552929
[No Abstract] [Full Text] [Related]
16. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma.
Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X
Front Oncol; 2023; 13():1182434. PubMed ID: 37346073
[TBL] [Abstract][Full Text] [Related]
17. A mitochondria-related signature for predicting immune microenvironment and therapeutic response in osteosarcoma.
Zhang L; Wu S; Huang J; Shi Y; Yin Y; Cao X
Front Oncol; 2022; 12():1085065. PubMed ID: 36531021
[TBL] [Abstract][Full Text] [Related]
18. Identification and Validation of a Novel Multiomics Signature for Prognosis and Immunotherapy Response of Endometrial Carcinoma.
Wu Z; Wang Q; Liu X; Zheng J; Ji L; Li X
J Oncol; 2022; 2022():8998493. PubMed ID: 36281289
[TBL] [Abstract][Full Text] [Related]
19. Development of a novel immune-related genes prognostic signature for osteosarcoma.
Wu ZL; Deng YJ; Zhang GZ; Ren EH; Yuan WH; Xie QQ
Sci Rep; 2020 Oct; 10(1):18402. PubMed ID: 33110201
[TBL] [Abstract][Full Text] [Related]
20. A more novel and powerful prognostic gene signature of lung adenocarcinoma determined from the immune cell infiltration landscape.
Ma C; Li F; He Z; Zhao S
Front Surg; 2022; 9():1015263. PubMed ID: 36311939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
